Celldex Therapeutics, Inc.
CLDX
$27.81
$1.144.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.85% | -21.44% | -18.27% | 71.22% | 221.23% |
| Total Receivables | -89.44% | -94.13% | -60.16% | -73.36% | 238.10% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -4.39% | 121.28% | 120.30% | 287.38% | 112.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -22.41% | -20.14% | -16.95% | 73.08% | 216.69% |
|
|
|||||
| Total Current Assets | -22.41% | -20.14% | -16.95% | 73.08% | 216.69% |
| Net Property, Plant & Equipment | 1.97% | 18.99% | 30.34% | 24.21% | 5.32% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.93% | 8,591.59% | 9,628.04% | 9,009.35% | 9,009.35% |
| Total Assets | -21.23% | -18.12% | -14.89% | 70.17% | 193.72% |
|
|
|||||
| Total Accounts Payable | 283.03% | -45.48% | 5.44% | -6.55% | -68.93% |
| Total Accrued Expenses | 40.81% | 52.87% | 45.16% | 53.62% | 52.69% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.62% | -3.34% | -8.82% | -10.04% | -10.86% |
| Total Finance Division Other Current Liabilities | -33.38% | -74.68% | -57.36% | -76.38% | -67.01% |
| Total Other Current Liabilities | -33.38% | -74.68% | -57.36% | -76.38% | -67.01% |
| Total Current Liabilities | 44.78% | 19.18% | 21.78% | 26.91% | 15.29% |
|
|
|||||
| Total Current Liabilities | 44.78% | 19.18% | 21.78% | 26.91% | 15.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -37.47% | 87.81% | 310.43% | 154.42% | 31.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -26.78% | -26.78% | -26.78% | -21.12% | -21.12% |
| Total Liabilities | 34.35% | 15.89% | 20.69% | 24.36% | 11.14% |
|
|
|||||
| Common Stock & APIC | 1.68% | 1.75% | 1.85% | 26.09% | 43.17% |
| Retained Earnings | -14.89% | -13.62% | -12.51% | -11.30% | -11.38% |
| Treasury Stock & Other | -28.80% | 87.58% | 59.00% | 0.18% | 147.68% |
| Total Common Equity | -23.86% | -19.45% | -16.17% | 74.06% | 218.54% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -23.86% | -19.45% | -16.17% | 74.06% | 218.54% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -23.86% | -19.45% | -16.17% | 74.06% | 218.54% |
|
|
|||||